Assignee profile:

G.D. Searle & Co.

City:

Chicago, Illinois

Country:

United States

Published Applications:

24

Last publication date:

2007-04-05

Patent Grants:

14

Last grant date:

2008-01-22

Top Inventors for applications by G.D. Searle & Co.

These are the the leading inventors for applications assigned to G.D. Searle & Co.:

Recent patent applications by G.D. Searle & Co.

G.D. Searle & Co. based in Chicago, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2007-04-05 ✅ Patent 7,320,983 granted on 2008-01-22
US20070078173A1
Chemistry; metallurgy

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

#2 | 2007-02-15 ✅ Patent 7,339,078 granted on 2008-03-04
US20070037754A1
Chemistry; metallurgy

Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

#3 | 2006-12-07 ✅ Patent 7,531,538 granted on 2009-05-12
US20060276493A1
Chemistry; metallurgy

α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

#4 | 2006-11-30
US20060270855A1
Chemistry; metallurgy

Methods of preparing retroviral proteases inhibitor intermediates

#5 | 2006-11-23
US20060264483A1
Chemistry; metallurgy

Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors

#6 | 2006-10-26
US20060240410A1
Human necessities

Retroviral protease inhibitor combinations

#7 | 2006-09-07 ✅ Patent 7,297,793 granted on 2007-11-20
US20060199822A1
Chemistry; metallurgy

Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors

#8 | 2006-08-24
US20060189611A1
Chemistry; metallurgy

Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

#9 | 2006-05-04 ✅ Patent 7,232,817 granted on 2007-06-19
US20060094789A1
Chemistry; metallurgy

α- and β-amino acid hydroxyethlamino sulfonyl urea derivatives useful as retroviral protease inhibitors

#10 | 2006-04-06 ✅ Patent 7,192,983 granted on 2007-03-20
US20060074247A1
Chemistry; metallurgy

N-protected/N-substituted-beta-amino hydroxy sulfonates

#11 | 2006-02-23
US20060040974A1
Chemistry; metallurgy

Retroviral protease inhibitors

#12 | 2006-01-26 ✅ Patent 7,199,158 granted on 2007-04-03
US20060020009A1
Chemistry; metallurgy

Succinoylamino hydroxyethylamino sulfonyl urea derivatives useful as retroviral protease inhibitors

#13 | 2005-12-01
US20050267302A1
Chemistry; metallurgy

Eplerenone crystalline form exhibiting enhanced dissolution rate

#14 | 2005-12-01 ✅ Patent 7,202,258 granted on 2007-04-10
US20050267214A1
Chemistry; metallurgy

α- and β-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors

#15 | 2005-12-01 ✅ Patent 7,141,609 granted on 2006-11-28
US20050267171A1
Chemistry; metallurgy

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

#16 | 2005-10-13 ✅ Patent 7,161,033 granted on 2007-01-09
US20050227926A1
Chemistry; metallurgy

Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors

#17 | 2005-08-04 ✅ Patent 7,189,864 granted on 2007-03-13
US20050171366A1
Chemistry; metallurgy

Method of preparing intermediates useful in synthesis of retroviral protease inhibitors

#18 | 2005-06-16 ✅ Patent 7,060,851 granted on 2006-06-13
US20050131075A1
Chemistry; metallurgy

Method of preparing retroviral protease inhibitor intermediates

#19 | 2005-06-16
US20050131050A1
Chemistry; metallurgy

Substituted pyrazolyl benzenesulfonamides for the treatment of inflamation

#20 | 2005-03-03 ✅ Patent 7,109,211 granted on 2006-09-19
US20050049252A1
Chemistry; metallurgy

Substituted benzopyran derivatives for the treatment of inflammation

#21 | 2005-02-10
US20050032795A1
Chemistry; metallurgy

2-Amino-benzoxazinones for the treatment of herpes simplex virus

#22 | 2005-02-10
US20050032793A1
Chemistry; metallurgy

2-amino-benzoxazinones for the treatment of viral infections

#23 | 2005-01-13
US20050010050A1
Chemistry; metallurgy

Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of COX-2-mediated disorders

#24 | 2005-01-06 ✅ Patent 7,038,084 granted on 2006-05-02
US20050004043A1
Chemistry; metallurgy

Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

AssigneeID:

277180 ⎘